Antifibrillatory actions of bepridil and butyl-MDI, two intracellular calcium antagonists
- 1 April 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 111 (1) , 9-15
- https://doi.org/10.1016/0014-2999(85)90107-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of Bepridil on Regional and Global Myocardial Ischemia/Reperfusion-Induced InjuryPharmacology, 1985
- Norepinephrine-induced contractions of the rat aorta in the absence of extracellular calcium-II. Effects of calcium antagonistsGeneral Pharmacology: The Vascular System, 1982
- Intracellular localization of the calcium antagonist propyl-methylenedioxyindene in cardiac tissueGeneral Pharmacology: The Vascular System, 1982
- Effects of tertiary and quaternary derivatives of aminomethylenedioxyindenes on some experimental arrhythmiasCanadian Journal of Physiology and Pharmacology, 1982
- Absence of blocking effects on cardiac slow calcium channels by the intracellular calcium antagonist 2-n-propyl-3-dimethylamino-5,6-methylenedioxyindeneCanadian Journal of Physiology and Pharmacology, 1982
- THE BENEFICIAL ACTIONS OF BEPRIDIL IN ACUTE MYOCARDIAL INFARCTION IN ANAESTHETIZED DOGSBritish Journal of Pharmacology, 1981
- Effects of 2-Substituted 3-Dimethylamino-5,6-Methylenedioxyindenes on Calcium-Induced ArrhythmiasJournal of Cardiovascular Pharmacology, 1981
- Antidysrhythmic and Electrophysiological Effects of a New Antianginal Agent, BepridilJournal of Cardiovascular Pharmacology, 1980
- Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and releaseThe American Journal of Cardiology, 1975
- Ventricular vulnerability during acute coronary occlusionThe American Journal of Cardiology, 1969